» Articles » PMID: 34926243

Development and Validation of a Predictive Scoring System for Colorectal Cancer Patients With Liver Metastasis: A Population-Based Study

Overview
Journal Front Oncol
Specialty Oncology
Date 2021 Dec 20
PMID 34926243
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Liver metastasis in colorectal cancer (CRC) is common and has an unfavorable prognosis. This study aimed to establish a functional nomogram model to predict overall survival (OS) and cancer-specific survival (CSS) in patients with colorectal cancer liver metastasis (CRCLM). A total of 9,736 patients with CRCLM from 2010 to 2016 were randomly assigned to training, internal validation, and external validation cohorts. Univariate and multivariate Cox analyses were performed to identify independent clinicopathologic predictive factors, and a nomogram was constructed to predict CSS and OS. Multivariate analysis demonstrated age, tumor location, differentiation, gender, TNM stage, chemotherapy, number of sampled lymph nodes, number of positive lymph nodes, tumor size, and metastatic surgery as independent predictors for CRCLM. A nomogram incorporating the 10 predictors was constructed. The nomogram showed favorable sensitivity at predicting 1-, 3-, and 5-year OS, with area under the receiver operating characteristic curve (AUROC) values of 0.816, 0.782, and 0.787 in the training cohort; 0.827, 0.769, and 0.774 in the internal validation cohort; and 0.819, 0.745, and 0.767 in the external validation cohort, respectively. For CSS, the values were 0.825, 0.771, and 0.772 in the training cohort; 0.828, 0.753, and 0.758 in the internal validation cohort; and 0.828, 0.737, and 0.772 in the external validation cohort, respectively. Calibration curves and ROC curves revealed that using our models to predict the OS and CSS would add more benefit than other single methods. In summary, the novel nomogram based on significant clinicopathological characteristics can be conveniently used to facilitate the postoperative individualized prediction of OS and CSS in CRCLM patients.

Citing Articles

Rapid detection of liver metastasis risk in colorectal cancer patients through blood test indicators.

Yu Z, Li G, Xu W Front Oncol. 2024; 14:1460136.

PMID: 39324006 PMC: 11422013. DOI: 10.3389/fonc.2024.1460136.


Multimodal Management of Colorectal Liver Metastases: State of the Art.

Filoni E, Musci V, Di Rito A, Inchingolo R, Memeo R, Mannavola F Oncol Rev. 2024; 17:11799.

PMID: 38239856 PMC: 10794467. DOI: 10.3389/or.2023.11799.


Tumor burden score dictates prognosis of patients with combined hepatocellular cholangiocarcinoma undergoing hepatectomy.

Deng G, Ren J, Wang H, Deng L, Chen Z, Fan Y Front Oncol. 2023; 12:977111.

PMID: 36755864 PMC: 9900097. DOI: 10.3389/fonc.2022.977111.


Nomogram Predicting the Survival of Young-Onset Patients with Colorectal Cancer Liver Metastases.

Cheng X, Li Y, Chen D, Xu X, Liu F, Zhao F Diagnostics (Basel). 2022; 12(6).

PMID: 35741205 PMC: 9221975. DOI: 10.3390/diagnostics12061395.


Development and validation of a prognostic scoring system for patients with colorectal cancer hepato-pulmonary metastasis: a retrospective study.

Deng S, Jiang Z, Cao Y, Gu J, Mao F, Xue Y BMC Cancer. 2022; 22(1):643.

PMID: 35690752 PMC: 9188712. DOI: 10.1186/s12885-022-09738-3.

References
1.
Hitpass L, Heise D, Schulze-Hagen M, Pedersoli F, Ulmer F, Amygdalos I . Primary Tumor Location Is a Prognostic Factor for Intrahepatic Progression-Free Survival in Patients with Colorectal Liver Metastases Undergoing Portal Vein Embolization as Preparation for Major Hepatic Surgery. Cancers (Basel). 2020; 12(6). PMC: 7352622. DOI: 10.3390/cancers12061638. View

2.
Zhang C, Li Y, Zhang Q, Biondi A, Fico V, Persiani R . The Prognostic Impact of the Metastatic Lymph Nodes Ratio in Colorectal Cancer. Front Oncol. 2019; 8:628. PMC: 6305371. DOI: 10.3389/fonc.2018.00628. View

3.
Zong Z, Zhou T, Rao L, Jiang Z, Li Y, Hou Z . Musashi2 as a novel predictive biomarker for liver metastasis and poor prognosis in colorectal cancer. Cancer Med. 2016; 5(4):623-30. PMC: 4831280. DOI: 10.1002/cam4.624. View

4.
Fong Y, Fortner J, Sun R, Brennan M, Blumgart L . Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg. 1999; 230(3):309-18; discussion 318-21. PMC: 1420876. DOI: 10.1097/00000658-199909000-00004. View

5.
Hackl C, Neumann P, Gerken M, Loss M, Klinkhammer-Schalke M, Schlitt H . Treatment of colorectal liver metastases in Germany: a ten-year population-based analysis of 5772 cases of primary colorectal adenocarcinoma. BMC Cancer. 2014; 14:810. PMC: 4230526. DOI: 10.1186/1471-2407-14-810. View